Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)

Cellebrite DI's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $276.0 million for Q4 2025.

• On a quarterly basis, Cash & Current Investments fell 5.95% year-over-year to $276.0 million in Q4 2025; TTM through Dec 2025 was $276.0 million, a 5.95% decrease from a year earlier, with the FY2025 full-year figure at $276.0 million, down 5.95% from the prior year.
• Cash & Current Investments slipped to $276.0 million in Q4 2025 per CLBT's latest filing, from $281.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $293.5 million in Q4 2024 and bottomed at $84.6 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $131.0 million (2022), against an average of $155.2 million.
• Biggest YoY gain for Cash & Current Investments was 106.35% in 2025; the steepest drop was 26.1% in 2025.
• Year by year, Cash & Current Investments stood at $146.0 million in 2021, then fell by 4.79% to $139.0 million in 2022, then jumped by 90.12% to $264.2 million in 2023, then climbed by 11.07% to $293.5 million in 2024, then fell by 5.95% to $276.0 million in 2025.
• Per Business Quant, the three latest CLBT Cash & Current Investments figures stand at $276.0 million (Q4 2025), $281.4 million (Q3 2025), and $179.2 million (Q2 2025).